Witherspoon Charles 4
4 · WEST PHARMACEUTICAL SERVICES INC · Filed Oct 31, 2024
Insider Transaction Report
Form 4
Witherspoon Charles
VP & Treasurer
Transactions
- Sale
Common Stock
2024-10-29$310.40/sh−478$148,371→ 1,478.141 total - Exercise/Conversion
Stock Options (Right to Buy)
2024-10-29−478→ 0 totalExercise: $173.22From: 2021-02-18Exp: 2030-02-18→ Stock Options (Right to Buy) (478 underlying) - Exercise/Conversion
Common Stock
2024-10-29$173.22/sh+478$82,799→ 1,956.141 total - Sale
Common Stock
2024-10-29$310.40/sh−225$69,840→ 1,253.141 total
Footnotes (1)
- [F1]This award vested in four equal annual installments beginning on February 18, 2021.